...

Top Indian Manufacturers Exporting Vaccines and Generic Drugs to Iran

Overview of India’s pharmaceutical industry and its global significance

India’s pharmaceutical industry is vital to the global market. It was valued at $42 billion in 2021 and is expected to grow to $130 billion by 2030.

India is skilled at making generic medicines and vaccines, making it a key health partner globally.

India has an impressive portfolio, producing over 60,000 generic drugs each year.

The vaccine industry plays a crucial global role in making affordable medicine accessible to people worldwide.

growth of indias pharmaceutical industry

Importance of Iran as a pharmaceutical export destination for Indian manufacturers

Iran is a major market for Indian pharmaceutical exports. A growing population and increasing healthcare demands offer a chance to boost trade and healthcare support.

  • Large Market:

Iran’s massive population creates a huge demand for pharmaceuticals. Millions require medical care, which creates a major opportunity for Indian companies.

  • Demand for Generics:

Iran relies on affordable generic medicines, a specialty of India.

This approach satisfies the country’s healthcare needs. It provides quality options at a reduced cost.

Importance of Iran as a pharmaceutical export destination for Indian manufacturers
  • Proximity and Logistics:

Being geographically close, India and Iran find trade easier.

This proximity helps cut down on shipping costs and time, which is beneficial to both countries in terms of their trade relations.

  • Government Support:

Iran’s government is guiding its pharmaceutical industry to new heights. India is welcoming foreign investment. It boosts local companies and fuels growth through teamwork.

India-Iran Pharmaceutical Trade Overview

India and Iran are building a stronger pharmaceutical trade. India exports important health products to satisfy Iran’s needs. Here’s an overview of key details:

  • In 2023, India exported $13.34 million in pharmaceutical products to Iran. This highlights a strong trade in health-related goods.

  • In 2023, India’s exports to Iran reached an impressive $1.19 billion. The main trade items were rice and soybean meal. Pharmaceutical exports also showed growth.

  • Vaccine exports from India to Iran increased by 50% between February 2023 and January 2024. India now leads the world in vaccine exports.

  • India’s trade with Iran has its ups and downs. India exported $74.7 million to Iran in November 2024, a drop from previous years.

Top Indian Manufacturers Exporting to Iran

India is a vital contributor to the global pharmaceutical market.

A number of major companies are currently providing their products to Iran.

Here are some of the top Indian manufacturers:

  • Actiza Pharmaceuticals Pvt. Ltd.

Actiza Pharmaceuticals Pvt. Ltd. is your go-to partner for excellent healthcare solutions in Iran.

we aim to meet global standards. we make high-quality generic medicines and special formulas for local needs.

we aim for a healthier tomorrow for everyone.

  • Cipla Limited

Cipla is a well-respected brand in the pharma business.

They are recognized for delivering top-notch medicines that won’t break the bank.

They supply a diverse selection of medicines for respiratory, heart, and infection issues.

  • Dr. Reddy’s Laboratories

Dr. Reddy’s Laboratories ships innovative drugs to more than 50 countries, including Iran.

They stick to high-quality standards, guaranteeing excellence at all times.

They offer reliable service with their solid distribution network.

  • Sun Pharmaceutical

Sun Pharma is a major player in the global pharma space, with a diverse lineup of generic and specialty medicines.

It operates in over 100 countries. It has 43 manufacturing facilities and is dedicated to quality and sustainability.

  • Zydus Cadila

Zydus Cadila has found its place in innovative and ethical pharmaceuticals.

We export to over 50 countries, making high-quality medications available.

We are truly dedicated to the Iranian market, where health and well-being are very important.

Key Drivers of India-Iran Pharmaceutical Trade

India and Iran’s pharmaceutical trade is expanding. Several key factors are driving this strong partnership.

  • In 2023, India exported a significant $13.34 million worth of pharmaceuticals to Iran. There is a constant demand for medicines in the country.

  • India’s top-quality, affordable medicines are a big plus for Iran’s healthcare system, and that is also helping to increase trade.

  • India’s strong economic ties and low prices make it a top choice for pharmaceutical imports in Iran.

Challenges

India and Iran’s pharmaceutical trade is facing key roadblocks.

These issues are blocking the smooth exchange of goods and services.

  • Sanctions: Sanctions against Iran are a major hurdle. They restrict the flow of essential medicines, posing a threat to public health.

  • Shipping Delays: Transportation issues, like slow customs and narrow shipping routes, lead to delays. Logistics problems lead to delays in the arrival of key pharmaceutical products.

  • Regulations: The rules in Iran can slow down the approval of medicines and vaccines. This can create challenges for Indian companies entering the market.

  • Market Competition: Indian pharma companies are competing with foreign firms and local suppliers. This competition takes away some of their market share and blocks their growth.

Challenges

Opportunities

The pharmaceutical trade between India and Iran is ready to grow. There are chances for innovation and stronger economic ties.

  • Vaccine Exports: India is a key player in vaccine exports, making a global impact. Iran’s demand is rising, which brings new opportunities.

  • Affordable Medicines: India can supply low-cost medicines, which helps meet Iran’s healthcare needs. This opens up new market opportunities.

  • Healthcare Demand: Iran’s expanding healthcare sector offers fresh opportunities for Indian firms. They can deliver essential medicines to meet the country’s medical demands.

  • Collaborative Efforts: India and Iran are working together to develop and research medicines. This partnership will boost the health sectors in both nations.

Opportunities

Statistical Highlights

India’s vaccine exports to Iran

India’s vaccine exports to Iran have seen changes in recent years. Here are the figures showing exports in USD over the last five years.

  • In 2019, India exported vaccines worth approximately USD 50 million to Iran.

  • In 2020, vaccine exports increased to around USD 63 million, marking a rise in demand.

  • In 2021, the export value decreased to USD 45 million, showing a shipment drop.

  • By 2022, exports had grown again to USD 58 million, indicating a steady recovery.

  • 2023 saw a 50% drop in exports to $30 million.

India’s Vaccine Exports to Iran (2019–2023)

Generic export exports to Iran:

India holds a vital position in the export of generics to Iran.

Generics comprise 70-75% of all pharmaceutical exports flowing to Iran.

This thriving trade highlights how India excels in providing affordable medication options.

India supplies the majority of these generic medicines, which are crucial to Iran’s healthcare system because of their affordability and accessibility.

Percentage of pharmaceuticals sourced from India:

India plays a crucial part in Iran’s pharmaceutical supply. The key points of this trade are as follows.

  • Iran imports over 40% of its pharmaceuticals from India.

  • India supplies the most generic drugs to Iran’s market.

  • Due to their lower costs and high quality, generics attract significant demand.

  • India’s pharmaceutical exports to Iran have increased lately.

Trends in vaccine coverage in Iran post-import from Indian manufacturers:

Iran has seen an improvement in vaccine coverage since vaccines were imported from India. Below are the trends:

  • Iran’s vaccination coverage has jumped by over 25% thanks to importing Indian vaccines.

  • Indian vaccines have made it easier for people in rural areas to get essential vaccines.

  • The import of vaccines from India has aided Iran’s COVID-19 vaccination program.

  • Vaccine availability is on the rise, and this is helping to improve public health outcomes.

How Indian generics improved accessibility to life-saving drugs in Iran

India’s generic medicines have had a significant impact on Iran. They have improved access to important vaccines and drugs.

  • Affordable Vaccines

Indian generics are changing vaccine affordability in Iran. These budget-friendly options help many people get vital shots without spending a lot.

  • Increased Supply

India is a significant supplier of vaccines to Iran. In 2023-24, the country delivered many vaccine shipments. This increased the availability of vaccines.

How Indian generics improved accessibility to life-saving drugs in Iran
  • Global Leader

India leads the world in vaccine exports, supplying over 210 countries, including Iran. This ensures a steady flow of vaccine availability.

  • Local Impact

These low-cost vaccines reduce Iran’s need for expensive imported medicines. This change makes it easier for everyone to access healthcare.

Future Prospects

India and Iran are in a position to boost their trade ties, and there is plenty of room for expansion in the years to come.

Here are some future trends in the pharma relations of India and Iran:

  • Growing Market

India and Iran are set to boost their pharma trade amid growing healthcare needs. India’s strong pharma production capacity will help lead this growth.

Future Prospects
  • Manufacturing Expansion

Iran can gain from India’s experience in medicine manufacturing. With more Indian companies potentially setting up plants in Iran, local production is likely to increase.

  • Better Collaboration

India and Iran are set to jointly develop new medicines and healthcare solutions by engaging in a strategic exchange of knowledge and technology.

Conclusion

India and Iran have forged a thriving pharmaceutical trade alliance.

India’s affordable, high-quality medicines are key to Iran’s healthcare system.

Generics and vaccines play a vital role, offering essential treatments at low prices.

They help fill health gaps, making sure everyone can access quality care.

As both countries grow their trade and work together, they can improve access to vital healthcare products.

This will benefit both nations in the future.

About the Author

Nilesh Mendpara MD of ACTIZA PHARMA Profile Image
Nilesh Mendpara

Nilesh Mendpara is the Managing Director of Actiza Pharmaceutical PVT. LTD., based in Surat, Gujarat, India. With over 10 years of experience in the pharmaceutical industry, Nilesh is passionate about spreading pharmaceutical knowledge and staying ahead of industry trends. He holds a Master of Pharmacy (Distinction) and a Bachelor's in Pharmacy from Rajiv Gandhi University of Health Sciences. Under his leadership, Actiza Pharmaceutical aims to be the most trusted partner for pharmaceutical exports worldwide, ensuring the highest standards of quality and safety. Connect with Nilesh to explore opportunities in advancing global healthcare.

[Read more]
Request A Call Back

We are a 100% export-oriented company and do not engage in domestic sales within India.